These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32929814)

  • 1. The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis.
    Peter EL; Nagendrappa PB; Kaligirwa A; Ogwang PE; Sesaazi CD
    Phytother Res; 2021 Feb; 35(2):637-656. PubMed ID: 32929814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.
    Peter EL; Kasali FM; Deyno S; Mtewa A; Nagendrappa PB; Tolo CU; Ogwang PE; Sesaazi D
    J Ethnopharmacol; 2019 Mar; 231():311-324. PubMed ID: 30385422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
    Peter EL; Deyno S; Mtewa A; Kasali FM; Nagendrappa PB; Sesaazi D; Tolo CU; Ogwang PE
    Syst Rev; 2018 Nov; 7(1):192. PubMed ID: 30442186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus.
    Peter EL; Mtewa AG; Nagendrappa PB; Kaligirwa A; Sesaazi CD
    Syst Rev; 2020 Jan; 9(1):7. PubMed ID: 31915054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007845. PubMed ID: 20166099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
    Wang Q; Wu X; Shi F; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():744-750. PubMed ID: 30551527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
    Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
    Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L.
    Nkambo W; Anyama NG; Onegi B
    Afr Health Sci; 2013 Dec; 13(4):933-9. PubMed ID: 24940315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactives of
    Xu B; Li Z; Zeng T; Zhan J; Wang S; Ho CT; Li S
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408574
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihyperglycemic effects of three extracts from Momordica charantia.
    Virdi J; Sivakami S; Shahani S; Suthar AC; Banavalikar MM; Biyani MK
    J Ethnopharmacol; 2003 Sep; 88(1):107-11. PubMed ID: 12902059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Momordica charantia and type 2 diabetes: from in vitro to human studies.
    Habicht SD; Ludwig C; Yang RY; Krawinkel MB
    Curr Diabetes Rev; 2014 Jan; 10(1):48-60. PubMed ID: 24295371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
    Hafizur RM; Kabir N; Chishti S
    Nat Prod Res; 2011 Feb; 25(4):353-67. PubMed ID: 21328131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
    Dans AM; Villarruz MV; Jimeno CA; Javelosa MA; Chua J; Bautista R; Velez GG
    J Clin Epidemiol; 2007 Jun; 60(6):554-9. PubMed ID: 17493509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice.
    Miura T; Itoh C; Iwamoto N; Kato M; Kawai M; Park SR; Suzuki I
    J Nutr Sci Vitaminol (Tokyo); 2001 Oct; 47(5):340-4. PubMed ID: 11814149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
    Ma C; Yu H; Xiao Y; Wang H
    Pharm Biol; 2017 Dec; 55(1):2170-2177. PubMed ID: 29110587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
    Cortez-Navarrete M; Martínez-Abundis E; Pérez-Rubio KG; González-Ortiz M; Méndez-Del Villar M
    J Med Food; 2018 Jul; 21(7):672-677. PubMed ID: 29431598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats.
    Ojewole JA; Adewole SO; Olayiwola G
    Cardiovasc J S Afr; 2006; 17(5):227-32. PubMed ID: 17117226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of
    Richter E; Geetha T; Burnett D; Broderick TL; Babu JR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.